Related Experiment Video
Updated: Sep 25, 2025

Intrarenal Injection of Escherichia coli in a Rat Model of Pyelonephritis
Published on: July 18, 2017
Short-course intravenous antibiotics for young infants with urinary tract infection
Jolie Lawrence1, Laure F Pittet2,3, Samar Hikmat3
1Department of General Medicine, The Royal Children's Hospital Melbourne, Parkville, Victoria, Australia jolie.lawrence@rch.org.au.
Insights
Shorter intravenous antibiotic courses for infant urinary tract infections (UTI) are safe, with low treatment failure rates. Early switch to oral antibiotics is feasible for non-bacteraemic UTI, provided meningitis is excluded.
Area of Science:
- Pediatric Infectious Diseases
- Antimicrobial Stewardship
- Neonatal Care
Background:
- Urinary tract infections (UTI) are common in young infants.
- Current practices often involve prolonged intravenous antibiotic courses.
- Shorter antibiotic durations offer potential benefits.
Purpose of the Study:
- To assess the safety of early intravenous-to-oral antibiotic switch in infants with UTI.
- To identify risk factors for bacteremia in infants with UTI.
- To evaluate the efficacy of short-course intravenous antibiotic treatment.
Main Methods:
- Retrospective audit of infants aged ≤90 days with UTI over 4 years.
- Data collected from electronic medical records and laboratory systems.
- Defined short-course intravenous antibiotics as <48 hours for non-bacteraemic UTI and <7 days for bacteraemic UTI.
Main Results:
- 60.2% of non-bacteraemic UTI cases received <48 hours of IV antibiotics.
- Treatment failure occurred in 1.3% of infants, primarily in non-bacteraemic cases.
- Bacteremia occurred in 5.3% of infants; fever and pyelonephritis predicted bacteremia.
Conclusions:
- Short-course IV antibiotics (<48 hours) are safe for non-bacteraemic UTI in young infants if meningitis is excluded.
- Treatment failure and serious complications were infrequent.
- Early switch to oral antibiotics can be considered.
Objective:
Shorter courses of intravenous antibiotics for young infants with urinary tract infection (UTI) have myriad advantages. As practice shifts toward shorter intravenous treatment courses, this study aimed to determine the safety of early intravenous-to-oral antibiotic switch and identify risk factors for bacteraemia with UTI.
Methods:
Retrospective audit of infants aged ≤90 days with a positive urine culture at a quaternary paediatric hospital over 4 years (2016-2020). Data were collected from the hospital electronic medical record and laboratory information system. Short-course intravenous antibiotic duration was defined as <48 hours for non-bacteraemic UTI and <7 days for bacteraemic UTI. Multivariate analysis was used to determine patient factors predicting bacteraemia.
Results:
Among 427 infants with non-bacteraemic UTI, 257 (60.2%) were treated for <48 hours. Clinicians prescribed shorter intravenous courses to infants who were female, aged >30 days, afebrile and those without bacteraemia or cerebrospinal fluid pleocytosis. Treatment failure (30-day UTI recurrence) occurred in 6/451 (1.3%) infants. All had non-bacteraemic UTI and one received <48 hours of intravenous antibiotics. None had serious complications (bacteraemia, meningitis, death). Follow-up audiology occurred in 21/31 (68%) infants with cerebrospinal fluid pleocytosis, and one had sensorineural hearing loss. Bacteraemia occurred in 24/451 (5.3%) infants, with 10 receiving <7 days intravenous antibiotics with no treatment failure. Fever and pyelonephritis were independent predictors of bacteraemia.
Conclusion:
Short-course intravenous antibiotics for <48 hours for young infants with non-bacteraemic UTI should be considered, provided meningitis has been excluded. Treatment failure and serious complications were rare in young infants with UTI.
Related Concept Videos
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Urinary Tract Infection IV: Nursing Management
Acute Pyelonephritis II: Diagnostic Studies and Management
Urinary Tract Infection I: Introduction
Urine Studies II: Urine Culture and Sensitivity Test
Acute Pyelonephritis I: Introduction

